Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECHNOLOGY
BIOCON LTD.
Biocon Ltd.
NSE: BIOCON | BSE: 532523
Mid-range Performer
Download real time
Clinical Trials
Patent Approvals
412.75
0.00
(
0.00
%)
1.5M
NSE+BSE Volume
NSE
20 Aug, 2026 2:23 PM (IST)
Watchlist
Portfolio
Alert
My Notes
US FDA Approval
Biocon gets US FDA nod for Yesintek prefilled single-dose autoinjector, targeting a $6.4 bn market
See details
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
GET EVENTS ALERTS
LIVE SAMPLE
Daily Digest
Biocon Split history
Biocon has not split the face value of the share since Jan 1, 2000.
See all forthcoming Bonus and Splits